149
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials

, , , , , , & show all
Pages 1233-1240 | Published online: 16 Apr 2019

References

  • SchwartzGGGanzPWatersDArikianSPharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromesAm J Cardiol2003921109111214583367
  • BerwangerOSantucciEVde BarrosESilvaPGMEffect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trialJAMA20183191331134010.1001/jama.2018.244429525821
  • PattiGCannonCPMurphySAClinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studiesCirculation20111231622163210.1161/CIRCULATIONAHA.110.00245121464051
  • WinchesterDEWenXXieLBavryAAEvidence of pre-procedural statin therapy a meta-analysis of randomized trialsJ Am Coll Cardiol2010561099110910.1016/j.jacc.2010.04.02320825761
  • GibsonCMPrideYBHochbergCPEffect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: a PROVE IT-TIMI 22 (Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22) substudyJ Am Coll Cardiol2009542290229510.1016/j.jacc.2009.09.01019958964
  • EisenALeshem-LevDYavinHEffect of high dose statin pretreatment on endothelial progenitor cells after percutaneous coronary intervention (HIPOCRATES study)Cardiovasc Drugs Ther20152912913510.1007/s10557-015-6575-825712416
  • DavignonJBeneficial cardiovascular pleiotropic effects of statinsCirculation2004109III39III4310.1161/01.CIR.0000131517.20177.5a15198965
  • RosensonRSTangneyCCAntiatherothrombotic properties of statins: implications for cardiovascular event reductionJAMA1998279164316509613915
  • IbanezBJamesSAgewallS2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)Eur Heart J20183911917710.1093/eurheartj/ehx39328886621
  • AmsterdamEAWengerNKBrindisRG2014 AHA/ACC guideline for the management of patients with Non-ST-Elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146424e139e22810.1016/j.jacc.2014.09.01725260718
  • MoherDLiberatiATetzlaffJAltmanDGPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementJ Clin Epidemiol2009621006101210.1016/j.jclinepi.2009.06.00519631508
  • HigginsJGreenSCochrane Handbook for Systematic Reviews of InterventionsOxford (UK)Cochrane Collaboration2008
  • JangYZhuJGeJKimY-JJiCLamWPreloading with atorvastatin before percutaneous coronary intervention in statin-naive Asian patients with non-ST elevation acute coronary syndromes: a randomized studyJ Cardiol20146333534310.1016/j.jjcc.2013.09.01224216317
  • KimJSKimJChoiDEfficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trialJACC Cardiovasc Interv2010333233910.1016/j.jcin.2009.11.02120298994
  • PattiGPasceriVColonnaGAtorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trialJ Am Coll Cardiol2007491272127810.1016/j.jacc.2007.02.02517394957
  • PostSPostMCvan den BrandenBJEarly statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trialCatheter Cardiovasc Interv20128075676510.1002/ccd.2344922419603
  • YuXLZhangHJRenSDEffects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injuryCoron Artery Dis201122879110.1097/MCA.0b013e328341baee21169815
  • WangCYLiuPYLiaoJKPleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends Mol Med200814374410.1016/j.molmed.2007.11.00418068482
  • NohriaAPrsicALiuPYStatins inhibit Rho kinase activity in patients with atherosclerosisAtherosclerosis200920551752110.1016/j.atherosclerosis.2008.12.02319167712
  • ShimomuraMOyamaJTakeuchiMAcute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial)Heart Vessels2016311583158910.1007/s00380-015-0773-y26699899
  • HahnJYKimHJChoiYJEffects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionAm Heart J20111621026103310.1016/j.ahj.2011.08.01122137076
  • WangLPengPZhangOHigh-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trialsPLoS One20149e11335210.1371/journal.pone.011335225473831
  • BenjoAMEl-HayekGEMesserliFHigh dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trialsCatheter Cardiovasc Interv201585536010.1002/ccd.2530224272891
  • VeselkaJZemanekDHajekPEffect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary interventionAm J Cardiol20111071295129910.1016/j.amjcard.2010.12.04021349484